InvestorsHub Logo
Followers 1
Posts 197
Boards Moderated 0
Alias Born 12/21/2018

Re: None

Monday, 07/29/2019 9:03:48 AM

Monday, July 29, 2019 9:03:48 AM

Post# of 50157
FINANCE
Delcath Enhances Board of Directors With Appointment of Commercial Leader, John R. Sylvester
GlobeNewswireJuly 29, 2019, 12:00 PM UTC
Seasoned leader with successful track record joins to help Delcath in the next phase of its development.

NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTC Pink: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that John R. Sylvester, a pharmaceutical and medical device executive with a greater than 30-year career focused on growing business, creating markets and implementing commercialization strategies, has joined the Delcath Board of Directors effective July 24, 2019.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News